Condition
Growth and Tolerance
Total Trials
3
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Completed3
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT04105686Not ApplicableCompletedPrimary
Growth and Tolerance of Young Infants Fed Infant Formula
NCT01808105Not ApplicableCompletedPrimary
Growth and Tolerance of Infants Fed Infant Formulas
NCT02006992Not ApplicableCompletedPrimary
Growth of Infants Fed Hydrolysate Formulas
Showing all 3 trials